Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00754923
What this trial is testing

Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Ohio State University Comprehensive Cancer Center 11
Early research (Phase 1)Looking for participantsNCT03819296
What this trial is testing

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Who this might be right for
Clinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8+41 more
M.D. Anderson Cancer Center 800
Large-scale testing (Phase 3)Study completedNCT03802240
What this trial is testing

Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 492
Testing effectiveness (Phase 2)UnknownNCT00003090
What this trial is testing

Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Cancer Biotherapy Research Group 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06885840
What this trial is testing

Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.

Who this might be right for
Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 100
Large-scale testing (Phase 3)Study completedNCT02504489
What this trial is testing

Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
BeyondSpring Pharmaceuticals Inc. 559
Not applicableLooking for participantsNCT05990946
What this trial is testing

Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer

Who this might be right for
Lung Neoplasms, Non-Small Cell Lung CancerPostoperative ComplicationsPatient Reported Outcome Measures+2 more
Zhongshan People's Hospital, Guangdong, China 736
Large-scale testing (Phase 3)Active Not RecruitingNCT06632327
What this trial is testing

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Who this might be right for
Resectable Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+1 more
Alliance for Clinical Trials in Oncology 37
Early research (Phase 1)Looking for participantsNCT05492682
What this trial is testing

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Who this might be right for
Melanoma (Skin)Triple-Negative Breast CancerNon-Small Cell Lung Cancer+5 more
Valo Therapeutics Oy 15
Not applicableStudy completedNCT03948724
What this trial is testing

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

Who this might be right for
Therapeutic Patient EducationImmune Checkpoint InhibitorsMelanoma+4 more
Institut Cancerologie de l'Ouest 412
Not applicableUnknownNCT03424980
What this trial is testing

Evaluate Effectiveness and Safety of Tyrosine Kinase Inhibitors

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Tang-Du Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01498562
What this trial is testing

Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Yonsei University 160
Early research (Phase 1)Ended earlyNCT02199886
What this trial is testing

Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection

Who this might be right for
Lung Neoplasms
Boehringer Ingelheim 6
Not applicableUnknownNCT04858828
What this trial is testing

Investigation on Predictive Molecular Markers of Efficacy for Front-line Immunochemotherapy in Advanced NSCLC

Who this might be right for
Biomarkers
Zhou Chengzhi 200
Testing effectiveness (Phase 2)Study completedNCT02392507
What this trial is testing

Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC

Who this might be right for
Carcinoma, Non-Small Cell Lung Cancer (NSCLC)
Eli Lilly and Company 54
Large-scale testing (Phase 3)Not Yet RecruitingNCT05767892
What this trial is testing

YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

Who this might be right for
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Suzhou Puhe Pharmaceutical Technology Co., LTD 350
Early research (Phase 1)Study completedNCT02668393
What this trial is testing

Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 14
Not applicableActive Not RecruitingNCT05382052
What this trial is testing

Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment

Who this might be right for
Non Small Cell Lung Cancer Stage IIINeoadjuvant Treatment
Fundación GECP 100
Early research (Phase 1)UnknownNCT05369312
What this trial is testing

Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients

Who this might be right for
Solid TumorNon-small Cell Lung CancerPancreatic Cancer+1 more
Betta Pharmaceuticals Co., Ltd. 230
Testing effectiveness (Phase 2)Ended earlyNCT02132598
What this trial is testing

Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)Metastases to the Brain
Liza Villaruz, MD 5
Next Page